Trials / Completed
CompletedNCT00949754
Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation
A Multi-Center, Randomized, Double Blind, Active-Controlled, Parallel Group Clinical Study to Evaluate the Dose Effect of Intradermal Injections of Apitox vs. Histamine in Subjects With Osteoarthritis Symptoms of the Knee
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Apimeds, Inc. · Industry
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The study will evaluate Apitox, pure honeybee venom as a treatment for pain and inflammation of osteoarthritis of the knee.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | honeybee venom (Apitoxin (Korea) Apitox (USA)) | multiple intradermal injections of 100 ug pure honeybee venom |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2010-03-01
- Completion
- 2010-04-01
- First posted
- 2009-07-30
- Last updated
- 2010-05-05
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00949754. Inclusion in this directory is not an endorsement.